{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:23:06Z","timestamp":1774632186226,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic> (Mp) is the most detected bacterial pathogen in children with community-acquired pneumonia (CAP). Our primary objective was to compare the clinical presentation, clinical management, and outcomes of children with and without Mp CAP across 6 children\u2019s hospitals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Eligible children were 2 months old or above and diagnosed with CAP in a prospective multicenter cohort study between October 1, 2015 and June 31, 2018. Children were excluded if they had complex chronic conditions. Children were tested for Mp via polymerase chain reaction assays. Clinical outcomes included hospitalization, and among hospitalized children length of stay, pediatric intensive care unit (PICU) admission, and rehospitalization within 8 weeks of discharge. Negative binomial and logistic regression were performed to determine the association of Mp with clinical outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 415 children included, 38 (7.4%) had Mp detected. Children with Mp were older [median interquartile range age 8.8 (3.1, 13.0) vs. 4.6 (interquartile range: 2, 8.2)\u00a0y], more likely to receive azithromycin (68.4% vs. 22.2%) and more likely to receive antibiotics in the prior 2 weeks (63.2% vs. 35.7%) versus those with non-Mp CAP. Children with Mp CAP were 33% less likely to stay in the hospital for an additional day (95% CI: 0.48-0.94).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Children with Mp CAP are more likely to have a longer duration of symptoms, but there are no statistical differences in symptom prevalence, laboratory values, or radiographic findings. There was no statistical difference in clinical outcomes for children with Mp CAP suggesting that clinical presentation and outcomes are similar between Mp and non-Mp CAP. Polymerase chain reaction testing for Mp CAP may be the only way to discriminate between non-Mp and Mp CAP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000003338","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T13:00:59Z","timestamp":1739797259000},"page":"305-310","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Features and Management Strategies in Children With Mycoplasma Pneumoniae"],"prefix":"10.1097","volume":"41","author":[{"given":"Tamara","family":"Garcia","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital Colorado and University of Colorado, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"Florin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Leonard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital Colorado and University of Colorado, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Ruddy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Wallihan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nationwide Children\u2019s Hospital, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita P.","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospitals \/Rainbow Babies and Children's Hospital, Cleveland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherman","family":"Alter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dayton Children\u2019s Hospital, Dayton"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"El-Assal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Akron Children's Hospital, Akron"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Marzec","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nationwide Children\u2019s Hospital, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Keaton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, ProMedica Toledo Children\u2019s Hospital, Toledo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Wook","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nationwide Children\u2019s Hospital, Columbus"},{"name":"Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Leber","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nationwide Children\u2019s Hospital, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuncion","family":"Mejias","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children\u2019s Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nationwide Children\u2019s Hospital, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children\u2019s Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilliam","family":"Ambroggio","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital Colorado and University of Colorado, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Children\u2019s Hospitals Initiative for Research in Pneumonia (CHIRP)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"R1-20250519","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cid\/ciy419","article-title":"Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia","volume":"68","author":"Kutty","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R2-20250519","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1016\/S2666-5247(23)00182-9","article-title":"Mycoplasma pneumoniae: gone forever?","volume":"4","author":"Meyer Sauteur","year":"2023","journal-title":"Lancet Microbe"},{"key":"R5-20250519","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"R6-20250519","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1086\/319981","article-title":"Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections","volume":"32","author":"Principi","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R7-20250519","first-page":"CD009175","article-title":"Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia","volume":"10","author":"Wang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250519","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R9-20250519","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1542\/hpeds.2020-005215","article-title":"Mycoplasma pneumoniae testing and treatment among children with community-acquired pneumonia","volume":"11","author":"Desai","year":"2021","journal-title":"Hosp Pediatr"},{"key":"R10-20250519","doi-asserted-by":"crossref","first-page":"e20181056","DOI":"10.1542\/peds.2018-1056","article-title":"Antibiotic prescribing for children in United States Emergency Departments: 2009-2014","volume":"143","author":"Poole","year":"2019","journal-title":"Pediatrics"},{"key":"R12-20250519","first-page":"e00968","article-title":"Macrolide-resistant Mycoplasma pneumoniae in the United States as determined from a National Surveillance Program","author":"Waites","year":"2019","journal-title":"J Clin Microbiol"},{"key":"R13-20250519","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/jamapediatrics.2017.3225","article-title":"Effectiveness of beta-lactam monotherapy vs macrolide combination therapy for children hospitalized with pneumonia","volume":"171","author":"Williams","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R14-20250519","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front Microbiol"},{"key":"R15-20250519","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/INF.0000000000003475","article-title":"Clinical characteristics and etiology of community-acquired pneumonia in US Children, 2015-2018","volume":"41","author":"Yun","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20250519","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1542\/hpeds.2018-0014","article-title":"Clinical risk factors for revisits for children with community-acquired pneumonia","volume":"8","author":"Ambroggio","year":"2018","journal-title":"Hosp Pediatr"},{"key":"R17-20250519","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"R18-20250519","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jpids\/piw091","article-title":"Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia","volume":"7","author":"Stockmann","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R19-20250519","doi-asserted-by":"crossref","first-page":"e01498","DOI":"10.1128\/JCM.01498-20","article-title":"Evaluation of IgM lateral flow assay as screening tool for Mycoplasma pneumoniae infection in childhood pneumonia","volume":"58","author":"Meyer Sauteur","year":"2020","journal-title":"J Clin Microbiol"},{"key":"R20-20250519","first-page":"41","article-title":"Interpretation of the paediatric chest X-ray","volume":"1","author":"Arthur","year":"2000","journal-title":"Paediatr Respir Rev"},{"key":"R21-20250519","doi-asserted-by":"crossref","first-page":"113333","DOI":"10.1016\/j.jpeds.2023.01.010","article-title":"Association of radiology findings with etiology of community acquired pneumonia among children","volume":"261","author":"Arnold","year":"2023","journal-title":"J Pediatr"},{"key":"R22-20250519","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ppul.23312","article-title":"Beta-lactam versus beta- lactam\/macrolide therapy in pediatric outpatient pneumonia","volume":"51","author":"Ambroggio","year":"2016","journal-title":"Pediatr Pulmonol"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000003338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T14:01:05Z","timestamp":1747663265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000003338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000003338","relation":{},"ISSN":["0749-5161","1535-1815"],"issn-type":[{"value":"0749-5161","type":"print"},{"value":"1535-1815","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"2024-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}